X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3543) 3543
Newsletter (728) 728
Newspaper Article (375) 375
Book Chapter (46) 46
Transcript (39) 39
Magazine Article (13) 13
Conference Proceeding (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prothrombin complex concentrate (3071) 3071
humans (2251) 2251
hemophilia (1712) 1712
hematology (1271) 1271
male (944) 944
prothrombin (944) 944
thrombin (877) 877
female (697) 697
anticoagulants (612) 612
research (611) 611
warfarin (599) 599
peripheral vascular disease (572) 572
hemophilia b (545) 545
adult (512) 512
middle aged (504) 504
blood coagulation factor viii (485) 485
care and treatment (451) 451
aged (440) 440
hemorrhage (437) 437
analysis (428) 428
surgery (416) 416
blood coagulation factors - therapeutic use (392) 392
gene therapy (384) 384
anticoagulants - adverse effects (378) 378
plasma (378) 378
activated factor-vii (373) 373
animals (369) 369
management (362) 362
bleeding (361) 361
coagulation (356) 356
fresh-frozen plasma (353) 353
medical research (338) 338
reversal (326) 326
dabigatran (324) 324
health aspects (314) 314
rivaroxaban (308) 308
medicine, experimental (306) 306
international normalized ratio (290) 290
treatment outcome (287) 287
safety (284) 284
prothrombin time (283) 283
thrombosis (281) 281
recombinant factor viia (279) 279
hemostasis (260) 260
blood (256) 256
anticoagulants - therapeutic use (253) 253
therapy (248) 248
intracranial hemorrhage (242) 242
risk factors (242) 242
hemorrhage - drug therapy (234) 234
hemorrhage - chemically induced (232) 232
blood coagulation - drug effects (228) 228
clinical trials (228) 228
administration, oral (225) 225
atrial-fibrillation (223) 223
recombinant proteins - therapeutic use (220) 220
aged, 80 and over (219) 219
coagulopathy (217) 217
adolescent (216) 216
patients (216) 216
retrospective studies (215) 215
anticoagulants - administration & dosage (210) 210
anticoagulation (210) 210
intracerebral hemorrhage (210) 210
prothrombin complex concentrates (210) 210
thromboembolism (210) 210
factor ix (202) 202
efficacy (201) 201
hemophilia a - drug therapy (201) 201
anesthesiology (200) 200
genes (199) 199
mortality (198) 198
hemorrhage - prevention & control (196) 196
physical fitness (189) 189
blood coagulation factors - administration & dosage (188) 188
medicine & public health (185) 185
child (183) 183
inhibitors (183) 183
abridged index medicus (182) 182
blood coagulation tests (176) 176
pharmaceutical industry (175) 175
genetic research (171) 171
young adult (171) 171
warfarin - adverse effects (168) 168
coagulation factors (167) 167
blood coagulation (166) 166
cardiac & cardiovascular systems (164) 164
hemophilia b - drug therapy (164) 164
partial thromboplastin time (164) 164
thrombin generation (164) 164
critical care medicine (161) 161
apixaban (160) 160
blood coagulation factors (156) 156
drug therapy (156) 156
emergency medicine (156) 156
medical examination (155) 155
factor ix - therapeutic use (154) 154
product development (153) 153
usage (153) 153
proteins (152) 152
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4639) 4639
German (55) 55
Spanish (31) 31
French (24) 24
Japanese (21) 21
Russian (10) 10
Italian (5) 5
Portuguese (4) 4
Hungarian (2) 2
Polish (2) 2
Czech (1) 1
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 02/2020, Volume 120, Issue 2, pp. 207 - 215
Abstract Background  Warfarin-associated major hemorrhage is frequently treated with prothrombin complex concentrates to correct international normalized ratio (INR). Objective... 
Coagulation and Fibrinolysis | MANAGEMENT | SAFETY | VITAMIN-K ANTAGONISTS | prothrombin complex concentrates | vitamin K antagonist | INTRACRANIAL HEMORRHAGE | warfarin | PLASMA | FEIBA | ANTICOAGULANT-THERAPY | anticoagulants | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | hemorrhage
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1234 - 1243
.... We performed a prospective clinical trial to compare nonactivated 4-factor prothrombin complex concentrate (4F-PCC... 
CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | vitamin K antagonist | prothrombin complex concentrates | PREVIOUSLY UNTREATED PATIENTS | INTRACRANIAL HEMORRHAGE | THERAPY | TRANSFUSION | REVERSING WARFARIN ANTICOAGULATION | anticoagulants | PERIPHERAL VASCULAR DISEASE | plasma | FRESH-FROZEN PLASMA | hemorrhage | TRAUMA | Single-Blind Method | Plasma | Prospective Studies | Thromboembolism - chemically induced | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Factor VII - therapeutic use | Emergencies | Anticoagulants - therapeutic use | Treatment Outcome | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Blood Coagulation Factors - adverse effects | Anticoagulants - pharmacology | Blood Coagulation Factors - therapeutic use | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Drug Combinations | Antidotes - therapeutic use | Antagonists (Biochemistry) | Usage | Care and treatment | Blood coagulation factors | Health aspects | Hemorrhage
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2009, Volume 69, Issue 14, pp. 1977 - 1984
Beriplex P/N, a prothrombin complex concentrate derived from pooled human plasma, contains the vitamin K-dependent coagulation factors II, VII, IX and X, and the vitamin K-dependent coagulation... 
Hemorrhage - drug therapy | Hypoprothrombinemias - drug therapy | Factor VII - therapeutic use | Factor IX - therapeutic use | Humans | Vitamin K Deficiency - drug therapy | Anticoagulants - therapeutic use | Factor X - therapeutic use | Prothrombin - therapeutic use | Drug Combinations
Journal Article
Journal Article